Genmab A/S annual ebitda
2017
2018
2019
Genmab A/S EBITDA Growth & History (GMAB)
Genmab A/S's calculated EBITDA was kr2.68B for fiscal 2019.
View full Genmab A/S company overviewGenmab A/S annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2019 | 2019-12-31 | kr2.68B | kr1.27B | +90.20% |
| 2018 | 2018-12-31 | kr1.41B | kr52.0M | +3.83% |
| 2017 | 2017-12-31 | kr1.36B | — | — |
Genmab A/S quarterly ebitda
No reported data
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|
Genmab A/S ebitda trends
Across the available reported history, Genmab A/S's ebitda increased from kr1.41B to kr2.68B, a change of kr1.27B.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Genmab A/S filings at SEC.gov ↗